Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians.
Muzumdar S, Skudalski L, Sharp K, Waldman RA.
Am J Clin Dermatol. 2022 Jan;23(1):61-67. doi: 10.1007/s40257-021-00646-z. Epub 2021 Dec 2.
[Redness of the skin].
Saib R, Raffray L, Bagny K.
Rev Med Interne. 2024 Mar;45(3):180-182. doi: 10.1016/j.revmed.2024.02.004. Epub 2024 Mar 4.
Erythema Multiforme: Recognition and Management.
Trayes KP, Love G, Studdiford JS.
Am Fam Physician. 2019 Jul 15;100(2):82-88.
Annular Lesions: Diagnosis and Treatment.
Trayes KP, Savage K, Studdiford JS.
Am Fam Physician. 2018 Sep 1;98(5):283-291.
Microbotox for facial redness.
Gaál M.
Int J Dermatol. 2024 May;63(5):553-554. doi: 10.1111/ijd.17114. Epub 2024 Mar 1.
Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management.
Khalil S, Kurban M, Abbas O.
J Am Acad Dermatol. 2022 Sep;87(3):614-622. doi: 10.1016/j.jaad.2020.05.113. Epub 2020 Jun 1.
Biophysical properties of redness-prone skin in Korean women.
Lee E, Cho C, Ha J.
J Cosmet Dermatol. 2022 Sep;21(9):4035-4041. doi: 10.1111/jocd.14722. Epub 2021 Dec 30.
Facial and neck erythema associated with dupilumab treatment: A systematic review.
Jo CE, Finstad A, Georgakopoulos JR, Piguet V, Yeung J, Drucker AM.
J Am Acad Dermatol. 2021 May;84(5):1339-1347. doi: 10.1016/j.jaad.2021.01.012. Epub 2021 Jan 8.
Analysis of facial redness by comparing VISIA and YLGTD.
Ma L, Huang X, Qiu Y, He Y.
Skin Res Technol. 2023 Jul;29(7):e13356. doi: 10.1111/srt.13356.
Topical steroid withdrawal: an emerging clinical problem.
Brookes TS, Barlow R, Mohandas P, Bewley A.
Clin Exp Dermatol. 2023 Aug 25;48(9):1007-1011. doi: 10.1093/ced/llad161.
